Skip to main content

Table 3 Trans fatty acid quartiles and risk of acute myocardial infarction, cardiovascular death and all-cause mortality

From: Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study

    Percentage by weight (wt%)    Concentration (mg/L)
Model AMI CV death All-cause mortality AMI CV death All-cause mortality
  HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI HR 95 % CI
Univariate             
Q2 1.13 0.66, 1.93 1.69 0.74, 3.87 1.29 0.71, 2.36 1.10 0.66, 1.83 1.05 0.51, 2.15 0.96 0.55, 1.69
Q3 1.49 0.90, 2.45 1.92 0.86, 4.27 1.73 0.99, 3.04 1.05 0.63, 1.75 0.74 0.34, 1.60 0.95 0.54, 1.65
Q4 1.36 0.82, 2.25 2.39 1.11, 5.14 2.24 1.32, 3.82 1.25 0.77, 2.05 1.53 0.79, 2.96 1.84 1.13, 3.00
P-trend 0.15   0.03   0.03   0.42   0.28   0.01  
P-interaction a 0.52   0.74   0.85   0.68   0.38   0.59  
Age and sex adjusted             
Q2 1.07 0.63, 1.84 1.36 0.59, 3.13 1.09 0.60, 2.01 1.11 0.67, 1.85 1.00 0.48, 2.04 0.94 0.54, 1.66
Q3 1.31 0.89, 2.18 1.23 0.54, 2.77 1.21 0.69, 2.15 1.02 0.61, 1.70 0.63 0.29, 1.38 0.85 0.49, 1.49
Q4 1.19 0.71, 2.00 1.44 0.65, 3.18 1.51 0.87, 2.62 1.25 0.76, 2.05 1.36 0.69, 2.65 1.73 1.06, 2.85
P-trend 0.41   0.45   0.10   0.46   0.49   0.02  
P-interaction a 0.68   0.48   0.74   0.64   0.29   0.51  
Multivariate adjustedb             
Q2 1.10 0.64, 1.90 1.43 0.62, 3.31 1.18 0.64, 2.17 1.08 0.65, 1.80 1.00 0.48, 2.07 0.97 0.55, 1.71
Q3 1.43 0.86, 2.39 1.36 0.60, 3.09 1.36 0.76, 2.41 1.02 0.61, 1.72 0.62 0.28, 1.37 0.89 0.50, 1.56
Q4 1.14 0.67, 1.92 1.39 0.62, 3.11 1.53 0.87, 2.67 1.11 0.67, 1.84 1.11 0.56, 2.21 1.54 0.93, 2.55
P-trend 0.49   0.54   0.11   0.74   0.92   0.08  
P-interaction a 0.64   0.72   0.80   0.77   0.41   0.74